Patent · US Active

Optimized parvovirus H-1 production

US12404498B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignee

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

Barbara Leuchs · Heidelberg, DE
Veronika FREHTMAN · Heidelberg, DE
Marcus Müller · Bad Rappenau, DE
Jean Rommelaere · Heidelberg, DE
Michael Dahm · Munich, DE
Ottheinz Krebs · Hersbruck, DE

Key dates

Filing date	Dec 6, 2021
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Jan 23, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14352
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides a robust single clone Master Cell Bank (MCB) for an optimized production of H-1 parvovirus (H-1 PV) which is suitable to increase infectious parvovirus production compared to standard producer NB-324K mixed cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.